Safety and One-Year revascularization outcome of excimer laser ablation therapy in treating in-stent restenosis of femoropopliteal arteries: A retrospective review from a single center

Cardiovascular Revascularization Medicine

Volumn 13, Issue 6, 2012, Pages 341-344

  Shammas, Nicolas W ^a   Shammas, Gail A ^a   Hafez, Alexander ^a   Kelly, Ryan ^a   Reynolds, Emily ^a   Shammas, Andrew N ^a  

^a MIDWEST CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

Atherectomy; Excimer Laser; Femoropopliteal segment; In stent restenosis; Long term outcome

Indexed keywords

ADULT; AGED; ARTERIAL STENT; ARTERY PERFORATION; ATHERECTOMY; BAILOUT STENTING; CLINICAL ARTICLE; DISTAL EMBOLIZATION; EMBOLIC PROTECTION FILTER; EMBOLISM; EXCIMER LASER; EXCIMER LASER ATHERECTOMY; FEMALE; FEMOROPOPLITEAL ARTERY; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; KAPLAN MEIER METHOD; LEG AMPUTATION; LEG ANGIOGRAPHY; LEG REVASCULARIZATION; MALE; MEDICAL RECORD REVIEW; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; TARGET LESION REVASCULARIZATION; TARGET VESSEL REVASCULARIZATION; TREATMENT OUTCOME;

CORONARY RESTENOSIS; FEMORAL ARTERY; HUMANS; LASERS, EXCIMER; PERCUTANEOUS CORONARY INTERVENTION; STENTS; TREATMENT OUTCOME;

EID: 84869407415     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2012.08.012     Document Type: Review

References (37)

1. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006, 354:1879-1888.
2. Laird J.R., Katzen B.T., Scheinert D., et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010, 3:267-276.
3. Schillinger M., Sabeti S., Dick P., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007, 115:2745-2749.
4. Laird J.R., Katzen B.T., Scheinert D., et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial. J Endovasc Ther 2012, 19:1-9. RESILIENT Investigators.
5. Iida O., Nanto S., Uematsu M., et al. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4 years. JACC Cardiovasc Interv 2009, 2:665-671.
6. Laird J.R. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 2006, 13(Suppl. 2):II30-II40.
7. Shammas N.W., Shammas G.A., Helou T.J., et al. Safety and 1-year revascularization outcome of SilverHawk atherectomy in treating in-stent restenosis of femoropopliteal arteries: a retrospective review from a single center. Cardiovasc Revasc Med 2012, 13:224-227.
8. Sixt S., Rastan A., Beschorner U., et al. Acute and long-term outcome of Silverhawk assisted atherectomy for femoro-popliteal lesions according the TASC II classification: a single-center experience. Vasa 2010, 39(3):229-236.
9. Zeller T., Rastan A., Sixt S., et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol 2006, 48:1573-1578.
10. Dick P., Sabeti S., Mlekush W., et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology 2008, 248:297-302.
11. Banerjee S, Das TS, Abu-Fadel MS et al. Pilot Trial of Cryoplasty or Conventional Balloon Post-Dilation of Nitinol Stents for Revascularization of Peripheral Arterial Segments: The COBRA Trial. J Am Coll Cardiol 2012. [Epub ahead of print]. http://www.ncbi.nlm.nih.gov/pubmed/22981558.
12. Dake M.D., Scheinert D., Tepe G., et al. Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther 2011, 18:613-623.
13. Wissgott C., Kamusella P., Andresen R. Treatment of in-stent reocclusions of femoropopliteal arteries with mechanical rotational catheters. Rofo 2011, 183:939-944.
14. Silingardi R., Cataldi V., Moratto R., et al. Mechanical thrombectomy in in-stent restenosis: preliminary experience at the iliac and femoropopliteal arteries with the Rotarex System. J Cardiovasc Surg (Torino) 2010, 51(4):543-550.
15. Yeo K.K., Malik U., Laird J.R. Outcomes following treatment of femoropopliteal in-stent restenosis: a single center experience. Catheter Cardiovasc Interv 2011, 78:604-608.
16. Trentmann J., Charalambous N., Djawanscher M., et al. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. Cardiovasc Surg (Torino). 2010, 51:551-560.
17. PATENT trial. Photo-Ablation Using the Turbo-Booster and Excimer Laser for In-Stent Restenosis Treatment study. Presented at LINC 2012 at the Leipzig Interventional Course, in Leipzig, Germany. Article online in Endovascular today http://www.bmctoday.net/evtoday/2012/01/article.asp?f=interim-results-presented-for-spectranetics-patent-study.
18. Laird J.R., Yeo K.K., Rocha-Singh K., et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv 2012, [Epub ahead of print]. 10.1002/ccd.23475.
19. Pershukov I.V., Niiazova-Karben Z.A., Batyraliev T.A., et al. Effectiveness of excimer laser coronary angioplasty in treatment of patients with in-stent restenosis. Kardiologiia 2003, 43:35-44.
20. Karaca I., Ilkay E., Akbulut M., Yavuzkir M. Treatment of in-stent restenosis with excimer laser coronary angioplasty. Jpn Heart J 2003, 44:179-186.
21. Dahm J.B. Excimer laser coronary angioplasty (ELCA) for diffuse in-stent restenosis: beneficial long-term results after sufficient debulking with a lesion-specific approach using various laser catheters. Lasers Med Sci 2001, 16:84-89.
22. Hamburger J.N., Foley D.P., de Feyter P.J., et al. Six-month outcome after excimer laser coronary angioplasty for diffuse in-stent restenosis in native coronary arteries. Am J Cardiol 2000, 86:390-394.
23. Topaz O., Bernardo N.L., Shah R., et al. Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris. Am J Cardiol 2001, 87:849-855.
24. Topaz O., Shah R., Mohanty P.K., et al. Application of excimer laser angioplasty in acute myocardial infarction. Laser Surg Med 2001, 29:185-192.
25. Topaz O., Minisi A.J., Bernardo N.L., et al. Alterations of platelet aggregation kinetics with ultraviolet laser emission: the "stunned platelet" phenomenon. Thromb Haemost 2001, 86:1087-1093.
26. Dahm J.B., Kuon E. High-energy eccentric excimer laser angioplasty for debulking diffuse in-stent restenosis leads to better acute- and 6-month follow-up results. J Invasive Cardiol 2000, 12:335-342.
27. Dormandy J.A., Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000, 31(1 Pt 2):S1-S296.
28. Bosiers M., Deloose K., Callaert J., et al. Results of the Protege EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions. J Vasc Surg 2011, 54:1042-1050.
29. Iida O., Soga Y., Hirano K., et al. Long-term outcomes and risk stratification of patency following nitinol stenting in the femoropopliteal segment: retrospective multicenter analysis. J Endovasc Ther 2011, 18:753-761.
30. Iida O., Uematsu M., Soga Y., et al. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses. Catheter Cardiovasc Interv 2011, 78:611-617.
31. Trabattoni D., Agrifoglio M., Cappai A., Bartorelli A.L. Incidence of stent fractures and patency after femoropopliteal stenting with the nitinol self-expandable SMART stent: a single-center study. J Cardiovasc Med (Hagerstown) 2010, 11:678-682.
32. Tosaka A., Soga Y., Iida O., et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012, 59:16-23.
33. Shammas N.W., Coiner D., Shammas G.A., et al. Distal embolic event protection using excimer laser ablation in peripheral vascular interventions: results of the DEEP EMBOLI registry. J Endovasc Ther 2009, 16:197-202.
34. Rastan A., Sixt S., Schwarzwälder U., et al. Initial experience with directed laser atherectomy using the Clirpath Photoablation Atherectomy System and Bias sheath in superficial femoral artery lesions. J Endovasc Ther 2007, 14:365-373.
35. Lam R.C., Shah S., Faries P.L., et al. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial artery. J Vasc Surg 2007, 46:1155-1159.
36. Shammas N.W., Dippel E.J., Coiner D., et al. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther 2008, 15:270-276.
37. Shammas N.W., Shammas G.A., Dippel E.J., et al. Predictors of distal embolization in peripheral percutaneous interventions: a report from a large peripheral vascular registry. J Invasive Cardiol 2009, 21:628-631.